Sheaff Brock Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $258K | Buy |
+2,299
| New | +$237K | 0.02% | 355 |
|
|
2024
Q3 | – | Sell |
-3,201
| Closed | -$220K | – | 470 |
|
|
2024
Q2 | $220K | Sell |
3,201
-690
| -18% | -$46K | 0.02% | 376 |
|
|
2024
Q1 | $285K | Sell |
3,891
-200
| -5% | -$15.4K | 0.02% | 364 |
|
|
2023
Q4 | $331K | Sell |
4,091
-1,000
| -20% | -$77.8K | 0.03% | 329 |
|
|
2023
Q3 | $382K | Hold |
5,091
| – | – | 0.03% | 288 |
|
|
2023
Q2 | $392K | Buy |
5,091
+25
| +0.5% | +$1.99K | 0.03% | 297 |
|
|
2023
Q1 | $420K | Hold |
5,066
| – | – | 0.04% | 286 |
|
|
2022
Q4 | $435K | Hold |
5,066
| – | – | 0.04% | 270 |
|
|
2022
Q3 | $313K | Hold |
5,066
| – | – | 0.03% | 319 |
|
|
2022
Q2 | $313K | Sell |
5,066
-400
| -7% | -$24.8K | 0.03% | 333 |
|
|
2022
Q1 | $325K | Sell |
5,466
-298
| -5% | -$19K | 0.02% | 358 |
|
|
2021
Q4 | $419K | Sell |
5,764
-397
| -6% | -$27.3K | 0.03% | 314 |
|
|
2021
Q3 | $430K | Sell |
6,161
-197
| -3% | -$13.8K | 0.03% | 296 |
|
|
2021
Q2 | $438K | Sell |
6,358
-496
| -7% | -$33.1K | 0.03% | 291 |
|
|
2021
Q1 | $443K | Sell |
6,854
-2,012
| -23% | -$130K | 0.03% | 273 |
|
|
2020
Q4 | $517K | Sell |
8,866
-3,301
| -27% | -$199K | 0.04% | 233 |
|
|
2020
Q3 | $769K | Buy |
12,167
+1,615
| +15% | +$112K | 0.07% | 163 |
|
|
2020
Q2 | $812K | Sell |
10,552
-238
| -2% | -$18.2K | 0.08% | 152 |
|
|
2020
Q1 | $807K | Sell |
10,790
-6,609
| -38% | -$457K | 0.11% | 119 |
|
|
2019
Q4 | $1.13M | Sell |
17,399
-2,449
| -12% | -$159K | 0.11% | 125 |
|
|
2019
Q3 | $1.26M | Sell |
19,848
-2,536
| -11% | -$166K | 0.14% | 111 |
|
|
2019
Q2 | $1.51M | Sell |
22,384
-1,074
| -5% | -$70.7K | 0.16% | 90 |
|
|
2019
Q1 | $1.52M | Sell |
23,458
-3,444
| -13% | -$229K | 0.19% | 97 |
|
|
2018
Q4 | $1.68M | Buy |
26,902
+1,862
| +7% | +$130K | 0.26% | 76 |
|
|
2018
Q3 | $1.93M | Sell |
25,040
-1,223
| -5% | -$92.4K | 0.18% | 84 |
|
|
2018
Q2 | $1.86M | Buy |
26,263
+991
| +4% | +$70K | 0.18% | 88 |
|
|
2018
Q1 | $1.91M | Sell |
25,272
-1,793
| -7% | -$143K | 0.2% | 82 |
|
|
2017
Q4 | $1.94M | Sell |
27,065
-2,751
| -9% | -$209K | 0.25% | 85 |
|
|
2017
Q3 | $2.42M | Buy |
29,816
+3,616
| +14% | +$277K | 0.32% | 70 |
|
|
2017
Q2 | $1.85M | Sell |
26,200
-3,985
| -13% | -$265K | 0.24% | 89 |
|
|
2017
Q1 | $2.05M | Sell |
30,185
-7,074
| -19% | -$497K | 0.27% | 80 |
|
|
2016
Q4 | $2.67M | Sell |
37,259
-5,269
| -12% | -$392K | 0.34% | 70 |
|
|
2016
Q3 | $3.37M | Sell |
42,528
-260
| -0.6% | -$21.1K | 0.45% | 51 |
|
|
2016
Q2 | $3.57M | Sell |
42,788
-1,307
| -3% | -$116K | 0.45% | 49 |
|
|
2016
Q1 | $4.05M | Sell |
44,095
-8,968
| -17% | -$809K | 0.5% | 42 |
|
|
2015
Q4 | $5.37M | Buy |
+53,063
| New | +$5.52M | 0.61% | 36 |
|
Other funds holding GILD
Sheaff Brock Investment Advisors's GILD Position: Q1 2025 in Review
Sheaff Brock Investment Advisors opened a new position in Gilead Sciences (GILD) in Q1 2025: 2,299 shares worth $258K. The stake represents 0.02% of the portfolio and ranks #355 among its holdings. This is a return to the name: Sheaff Brock Investment Advisors previously reported a position in GILD as recently as Q2 2024.
Sheaff Brock Investment Advisors first reported a position in GILD in Q4 2015 and has held it in 36 quarters since. The position peaked at $5.37M in Q4 2015. 2,014 funds tracked by Wall St. Rank hold GILD as of Q1 2025.
- Sheaff Brock Investment Advisors held 2,299 shares of Gilead Sciences worth $258K as of Q1 2025.
- Gilead Sciences was a new Sheaff Brock Investment Advisors position in Q1 2025.
- Gilead Sciences made up 0.02% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #355 holding.
- Sheaff Brock Investment Advisors first reported a position in Gilead Sciences in Q4 2015 and has held it in 36 quarters since.
- Sheaff Brock Investment Advisors's Gilead Sciences position peaked at $5.37M in Q4 2015.
- 2,014 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2025.
Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.